MEMO1, a new IRS1-interacting protein, induces epithelial-mesenchymal transition in mammary epithelial cells

Research output: Contribution to journalArticlepeer-review

56 Scopus citations

Abstract

MEMO1 (mediator of ErbB2-driven cell motility 1) regulates HER2-dependent cell migration. Increased MEMO1 expression is associated with cancer aggressiveness. Here, we found that MEMO1 is also involved in breast carcinogenesis via regulating insulin-like growth factor-I receptor-dependent signaling events. We showed that MEMO1 binds to insulin receptor substrate 1, activates the downstream PI3K/Akt signaling pathway, leads to upregulation of Snail1 and thereby triggers the epithelial-mesenchymal transition (EMT) program. In addition, MEMO1 overexpression is accompanied by growth factor-independent proliferation, anchorage-independent growth in soft agar, and enhanced metastatic potential. Together, these findings suggest that MEMO1 acts as an oncogene and is a potential therapeutic target for cancer treatment.

Original languageEnglish (US)
Pages (from-to)3130-3138
Number of pages9
JournalOncogene
Volume32
Issue number26
DOIs
StatePublished - Jun 27 2013

Keywords

  • EMT
  • IRS1
  • MEMO1
  • Snail1
  • breast cancer

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Fingerprint

Dive into the research topics of 'MEMO1, a new IRS1-interacting protein, induces epithelial-mesenchymal transition in mammary epithelial cells'. Together they form a unique fingerprint.

Cite this